Cargando…
Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis
There is increasing evidence that the Myocardin-related transcription factor/Serum response factor (MRTF/SRF) pathway plays a key role in fibroblast activation and that knocking down MRTF can lead to reduced scarring and fibrosis. Here, we have developed a receptor-targeted liposome-peptide-siRNA na...
Autores principales: | Yu-Wai-Man, Cynthia, Tagalakis, Aristides D., Manunta, Maria D., Hart, Stephen L., Khaw, Peng T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764806/ https://www.ncbi.nlm.nih.gov/pubmed/26905457 http://dx.doi.org/10.1038/srep21881 |
Ejemplares similares
-
Novel PEGylated Lipid Nanoparticles Have a High Encapsulation Efficiency and Effectively Deliver MRTF-B siRNA in Conjunctival Fibroblasts
por: Sanghani, Amisha, et al.
Publicado: (2021) -
In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
por: Tagalakis, Aristides D., et al.
Publicado: (2018) -
Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
por: Fernando, Owen, et al.
Publicado: (2018) -
Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis
por: Manunta, Maria D. I., et al.
Publicado: (2017) -
Systematic Comparisons of Formulations of Linear Oligolysine Peptides with siRNA and Plasmid DNA
por: Kwok, Albert, et al.
Publicado: (2016)